Singapore, 18-20 Jun 2018

Biotech Startup

RAISING EQUITY •
INVESTOR PITCHING •
IMPLEMENTATION STRATEGY

SET UP A BIOTECH COMPANY FROM SCRATCH

This course is designed to help those aspiring to set up their own life sciences company to avoid common pitfalls. The trainer will force you to ask the right questions and challenge your plan, to help delegates recognise the risks, increase chances of success and enhance return on investment.

develop new skills

Get to grips with preparing your company for funding and creating an investor pitch

gain strategic advantage

Discover how to build a discounted cash flow model and how to use it in licensing discussions

COMMERCIALISE IDEAS EMERGING FROM SCIENCE

This course provides perspective on the evolving landscape of biotechnology from the standpoint of new entrepreneurial companies. It focuses on changes and challenges in the industry, and opportunities for new entrants. The course is appropriate for those who wish to deepen their understanding of the biotechnology industry and the many entrepreneurial opportunities that the industry provides.

In just 3 days you will:

Get up to date with developments and opportunities in the biotech sector

Learn how to turn a good idea into a real business opportunity

Understand how to avoid common pitfalls in the start-up environment

Discover the various funding options available

Get to grips with operational strategy considerations in the biotech sector

Find out about business development and licensing strategies

Master the principles of negotiating a deal with Big Pharma

Finesse your people management skills

Look at the role and importance of leadership in a biotech company

Meet your instructor

Dr Simon Bennett is an independent consultant and registered Growth Coach with over twenty years of industry experience. He mentors and advises early-stage businesses and management teams, and has senior management experience from start-up through to IPO and trade sale, with responsibilities covering all aspects of business and corporate development. His experience spans bio-pharma, biotech, genomics and specialty pharma, as well as web 2.0. Simon currently manages a portfolio of around ten companies and is a board director of MitoDys Therapeutics and Xobaderm, until its recent acquisition by FTSE 100 Informa plc, was a non-executive director of colwiz. He is currently advising and providing business development support to several companies, including Bristol-Myers Squibb, Oxford Pharmacience, Beijing Tide Pharma and Xobaderm. He has been involved in over 70 commercial deals globally, with both Big Pharma and biotech companies. Simon is a trainer and runs a series of basic and advanced courses in Bio-Pharma Business Development, Biotech Deal Negotiating and Bio-entrepreneurship in Europe, North America, Russia/CIS, Latin America, Middle East and Asia.